| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
N/A |
| Shares
Out: |
26,519,000 |
| Market
Cap: |
19.81(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.55 - $1.72 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile VolitionRx is an epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop blood tests to help diagnose and monitor a range of life-altering diseases including certain cancers and diseases associated with NETosis such as sepsis and COVID-19. Co.'s tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Co. is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
99,000 |
210,422 |
928,911 |
| Total Buy Value |
$0 |
$73,100 |
$210,662 |
$1,588,869 |
| Total People Bought |
0 |
5 |
11 |
12 |
| Total Buy Transactions |
0 |
8 |
21 |
37 |
| Total Shares Sold |
0 |
40,000 |
40,000 |
54,949 |
| Total Sell Value |
$0 |
$33,000 |
$33,000 |
$69,924 |
| Total People Sold |
0 |
1 |
1 |
2 |
| Total Sell Transactions |
0 |
2 |
2 |
3 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gaetan Michel |
Manager-Belgian Volition SPRL |
– – – |
2020-08-17 |
4 |
D |
$3.50 |
$13,752 |
D/D |
(3,929) |
1,071 |
|
- |
|
| Gaetan Michel |
Manager-Belgian Volition SPRL |
– – – |
2020-08-17 |
4 |
OE |
$2.50 |
$13,750 |
D/D |
5,000 |
3,214 |
|
- |
|
| Innes Guy Archibald |
Director |
– • – |
2020-08-12 |
4 |
OE |
$2.50 |
$82,500 |
D/D |
30,000 |
1,384,975 |
|
- |
|
| Micallef Jacob Vincent |
Chief Scientific Officer |
• – – |
2020-08-10 |
4 |
D |
$3.50 |
$403,333 |
D/D |
(115,238) |
100,928 |
|
- |
|
| Micallef Jacob Vincent |
Chief Scientific Officer |
• – – |
2020-08-10 |
4 |
OE |
$2.50 |
$357,500 |
D/D |
130,000 |
161,008 |
|
- |
|
| Terrell Jason Bradley Md |
Chief Medical Officer |
• – – |
2020-08-04 |
4 |
D |
$3.55 |
$72,956 |
D/D |
(20,551) |
54,449 |
|
- |
|
| Terrell Jason Bradley Md |
Chief Medical Officer |
• – – |
2020-08-04 |
4 |
OE |
$2.50 |
$68,750 |
D/D |
25,000 |
65,420 |
|
- |
|
| Faulkes Martin Charles |
Director |
– • – |
2020-07-21 |
4 |
D |
$3.95 |
$198,847 |
D/D |
(50,341) |
1,570,943 |
|
- |
|
| Faulkes Martin Charles |
Director |
– • – |
2020-07-21 |
4 |
OE |
$2.50 |
$165,000 |
D/D |
60,000 |
1,597,120 |
|
- |
|
| Rootsaert Rodney Gerard |
Secretary |
• – – |
2020-07-21 |
4 |
D |
$3.95 |
$195,249 |
D/D |
(49,430) |
20,398 |
|
- |
|
| Rootsaert Rodney Gerard |
Secretary |
• – – |
2020-07-21 |
4 |
OE |
$2.50 |
$165,000 |
D/D |
60,000 |
46,214 |
|
- |
|
| Reynolds Cameron John |
President and CEO |
• • – |
2020-07-21 |
4 |
D |
$3.95 |
$331,405 |
D/D |
(83,900) |
1,142,373 |
|
- |
|
| Reynolds Cameron John |
President and CEO |
• • – |
2020-07-21 |
4 |
OE |
$2.50 |
$275,000 |
D/D |
100,000 |
1,186,000 |
|
- |
|
| Reynolds Cameron John |
President and CEO |
• • – |
2020-05-22 |
4 |
B |
$2.75 |
$11,000 |
D/D |
4,000 |
1,126,273 |
2.81 |
- |
|
| Futcher Edward |
Director |
– • – |
2020-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
38,250 |
|
- |
|
| Kway Jasmine |
|
– – – |
2020-03-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,400 |
|
- |
|
| Terrell Jason Bradley Md |
Chief Medical Officer |
• – – |
2020-01-12 |
4 |
D |
$4.79 |
$54,434 |
D/D |
(11,364) |
50,000 |
|
- |
|
| Reynolds Cameron John |
President and CEO |
• • – |
2019-12-05 |
4 |
B |
$4.24 |
$4,664 |
D/D |
1,100 |
1,122,273 |
2.73 |
- |
|
| Cotterford Co Ltd |
10% Owner |
– – • |
2019-10-01 |
4 |
B |
$5.69 |
$284,570 |
I/I |
50,000 |
11,706,913 |
1.5 |
- |
|
| Cotterford Co Ltd |
10% Owner |
– – • |
2019-09-26 |
4 |
S |
$6.03 |
$278,792 |
I/I |
(46,238) |
11,656,913 |
|
- |
|
| Faulkes Martin Charles |
Director |
– • – |
2019-08-27 |
4 |
B |
$3.75 |
$37,500 |
D/D |
10,000 |
1,561,284 |
2.39 |
- |
|
| Faulkes Martin Charles |
Director |
– • – |
2019-08-15 |
4 |
B |
$3.94 |
$197,000 |
D/D |
50,000 |
1,551,284 |
2.39 |
- |
|
| Cotterford Co Ltd |
10% Owner |
– – • |
2019-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,041,570 |
|
- |
|
| Faulkes Martin Charles |
Director |
– • – |
2019-06-11 |
4 |
B |
$3.10 |
$246,134 |
D/D |
79,269 |
1,501,284 |
2.39 |
- |
|
| Faulkes Martin Charles |
Director |
– • – |
2019-06-10 |
4 |
B |
$3.02 |
$213,608 |
D/D |
70,731 |
1,422,015 |
2.39 |
- |
|
305 Records found
|
|
Page 9 of 13 |
|
|
0.02 (2.97%) 
